Partial Trisomy
|
disease |
Pathological Conditions, Signs and Symptoms
|
Congenital Abnormality
|
29
|
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Persistent Hyperplastic Primary Vitreous
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases
|
Congenital Abnormality
|
33
|
4
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Morphologically altered structure
|
disease |
|
Anatomical Abnormality
|
46
|
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Nodular Goiter
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
55
|
12
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Chronic inflammatory disorder
|
group |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
74
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Multiple malignancy
|
phenotype |
Neoplasms
|
Neoplastic Process
|
163
|
3
|
0.020 |
None |
1.000 |
2 |
|
2015 |
2016 |
Basal-Like Breast Carcinoma
|
disease |
|
Neoplastic Process
|
245
|
9
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2019 |
Transitional cell carcinoma of bladder
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
333
|
158
|
0.020 |
None |
1.000 |
2 |
|
2013 |
2018 |
Invasive carcinoma of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
473
|
21
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
T-Cell Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
485
|
24
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Ewings sarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
517
|
25
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Mammary Neoplasms, Human
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
527
|
|
0.300 |
None |
1.000 |
1 |
|
2016 |
2016 |
Tumor Initiation
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
533
|
8
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Ovarian Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
539
|
19
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Mammary Carcinoma, Human
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
545
|
|
0.300 |
None |
1.000 |
1 |
|
2016 |
2016 |
Carcinoma breast stage IV
|
disease |
|
Neoplastic Process
|
573
|
14
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Dermatitis, Atopic
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases; Immune System Diseases
|
Disease or Syndrome
|
751
|
232
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Eczema
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
863
|
368
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Solid Neoplasm
|
phenotype |
Neoplasms
|
Neoplastic Process
|
1145
|
24
|
0.020 |
None |
1.000 |
2 |
|
2013 |
2017 |
Esophageal Neoplasms
|
group |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
1254
|
270
|
0.020 |
None |
1.000 |
2 |
|
2015 |
2017 |
Malignant neoplasm of esophagus
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
1286
|
214
|
0.020 |
None |
1.000 |
2 |
|
2015 |
2017 |
Esophageal carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
1287
|
272
|
0.020 |
None |
1.000 |
2 |
|
2015 |
2017 |
Papillary thyroid carcinoma
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
1348
|
204
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Depressed mood
|
phenotype |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
1461
|
269
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Nasopharyngeal carcinoma
|
disease |
Neoplasms; Stomatognathic Diseases; Otorhinolaryngologic Diseases
|
Neoplastic Process
|
1553
|
320
|
0.030 |
None |
1.000 |
3 |
|
2014 |
2019 |